Evan Kearns - 23 Jan 2024 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Legal Officer
Signature
/s/ Evan D. Kearns
Issuer symbol
COGT
Transactions as of
23 Jan 2024
Transactions value $
$0
Form type
4
Filing time
25 Jan 2024, 16:27:09 UTC
Previous filing
15 Feb 2023
Next filing
27 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +255,000 $0.000000 255,000 23 Jan 2024 Common Stock 255,000 $4.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.